Armata Pharmaceuticals (ARMP) Current Leases (2019 - 2026)

Armata Pharmaceuticals has disclosed Current Leases across 8 years of filings, most recently posting $4.6 million for Q1 2026.

• Current Leases for Q1 2026 came in at $4.6 million, up 3.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 million (up 3.01% YoY), and the FY2025 annual result was $4.6 million, up 3.0% from the prior year.
• Current Leases came in at $4.6 million for Q1 2026 at Armata Pharmaceuticals, up from $4.6 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $17.0 million in Q4 2022 to a low of $1.5 million in Q1 2022.
• The 5-year median for Current Leases is $4.6 million (2026), against an average of $7.0 million.
• Across the five-year window, Current Leases jumped 1027.3% in 2022 and slumped 62.85% in 2024, its largest moves.
• Armata Pharmaceuticals' Current Leases stood at $17.0 million in 2022, then plunged by 44.27% to $9.5 million in 2023, then sank by 53.26% to $4.4 million in 2024, then advanced by 3.0% to $4.6 million in 2025, then grew by 0.64% to $4.6 million in 2026.
• The last three Current Leases figures came in at $4.6 million (Q1 2026), $4.6 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.